[Form 4] VISA Inc. Insider Trading Activity
Visa Inc. (V) insider Ryan McInerney executed equity transactions under a 10b5-1 plan on 09/02/2025. The filing shows Mr. McInerney exercised 10,485 employee stock options at an exercise price of $109.82 and concurrently sold 10,485 Class A shares at a weighted-average price of $348.5653 (individual sale prices ranged $346.55–$349.31). After these transactions the filing reports 11,022 Class A shares beneficially owned directly and 247,326 Class A shares held indirectly through the Ryan and Angela McInerney Trust. The filing discloses the option grant date of 11/19/2017 and vesting in three equal annual installments, and it notes the transactions were made pursuant to a Rule 10b5-1 trading plan dated May 15, 2025.
- Transactions executed under a Rule 10b5-1 plan, providing documented affirmative defense conditions
- Complete disclosure of option exercise and sale prices, including range for disposals ($346.55–$349.31)
- Detailed beneficial ownership reported including direct and indirect holdings and option vesting schedule
- Insider sold 10,485 shares, representing a reduction of direct holdings (from 11,022 reported post-exercise to 537 reported after sale on the second line)
- Weighted-average sale price reported as $348.5653 without breakdown by individual trade in the form (the filer offers to provide details upon request)
Insights
TL;DR: Insider exercised options and sold an equal number of shares under a 10b5-1 plan, realizing proceeds at a ~3x multiple vs exercise price.
The report documents a routine option exercise and contemporaneous sale executed under a Rule 10b5-1 plan, with an exercise price of $109.82 and disposals at a weighted-average of $348.5653. The transaction size (10,485 shares) is modest relative to the reported indirect trust holdings of 247,326 shares. This filing is informational about insider liquidity actions but does not disclose company operational metrics or material corporate events.
TL;DR: Disclosure aligns with Section 16 reporting and cites an explicit 10b5-1 plan, indicating preplanned insider trading.
The Form 4 clearly states the trades were made pursuant to a Rule 10b5-1 trading plan dated May 15, 2025, which provides affirmative defense under Rule 10b5-1(c). The filing includes required option grant, vesting, and beneficial ownership details, and it is signed via attorney-in-fact, satisfying signature requirements. No governance concerns or unusual noncompliance are evident from the information provided.